Raymond James Reiterates Biohaven Buy
Raymond James maintains Strong Buy on Biohaven after positive trial data. Boosts stock outlook.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.